je.st
news
Home
› RTI-HS, FDA partner to study patients' preferences that contributed to approval of new obesity device
RTI-HS, FDA partner to study patients' preferences that contributed to approval of new obesity device
2015-02-02 14:32:07| Industrial Machines - Topix.net
RTI Health Solutions , a business unit of RTI International, partnered with the U.S. Food and Drug Administration to conduct a study on patients' preferences which contributed to the Agency's regulatory decision to approve the Maestro Rechargeable System, a first-of-kind device to treat obesity. In addition to clinical study results, FDA considered the study results to quantify patients' preferences for benefits and acceptability of risks of various obesity devices.
Tags: study
partner
device
approval
Category:Industrial Goods and Services